STOCK TITAN

National CineMedia (NCMI) Form 144: Proposed 30,971-Share Sale via J.P. Morgan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed for National CineMedia, Inc. (NCMI) reports a proposed sale of 30,971 common shares through J.P. Morgan Securities on 09/25/2025 on the Nasdaq with an aggregate market value of $146,493. The shares reported were acquired from the issuer: 28,818 shares from a PSU vest on 08/04/2022, 1,833 shares as compensation on 02/24/2020, and 320 shares as compensation on 12/02/2019. The filer states there were no sales in the past three months to report and makes the standard representation about absence of undisclosed material adverse information.

Positive

  • Full disclosure of acquisition history showing dates and nature (PSU vest, compensation) for all shares being sold
  • Broker and execution details provided (J.P. Morgan Securities; Nasdaq; execution date 09/25/2025)
  • No sales in the past three months reported, indicating this is not part of a rapid disposal sequence

Negative

  • None.

Insights

TL;DR: Insider plans a routine sale of 30,971 NCMI shares acquired from compensation and PSU vesting, modest in market value.

The filing documents a single proposed sale of 30,971 common shares valued at $146,493 to execute on 09/25/2025 via J.P. Morgan Securities. Acquisition dates show typical compensation timing and a PSU vesting event; there are no reported sales in the prior three months. This appears to be a routine insider liquidity event rather than a large, potentially market-moving disposal given the small percentage implied by the outstanding share count of 174,065,873. The filing includes the required representation about material nonpublic information.

TL;DR: The disclosure fulfills Rule 144 notice requirements for an insider sale; documentation is standard and complete.

Information provided includes broker, share count, market value, acquisition method, and dates, satisfying the notice elements. The filer confirms no recent sales and makes the customary attestation regarding material information. There is no indication in the filing of reliance on Rule 10b5-1 plans or other atypical arrangements. From a governance standpoint, the form is routine and compliant based on the data presented.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does NCMI Form 144 disclose about the proposed sale?

The filing states a proposed sale of 30,971 common shares via J.P. Morgan Securities on 09/25/2025 with an aggregate market value of $146,493.

How were the shares being sold acquired according to the filing?

Shares were acquired from the issuer: 28,818 via a PSU vest on 08/04/2022, 1,833 as compensation on 02/24/2020, and 320 as compensation on 12/02/2019.

Does the Form 144 report any sales in the past three months for NCMI?

No. The filing explicitly states Nothing to Report for securities sold during the past three months.

Which broker and exchange are listed for the proposed sale?

The broker is J.P. Morgan Securities LLC and the exchange listed is Nasdaq.

What representation does the filer make about material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.